Projects that make the world a better place.
FABA VENTURES Investing in bonds with a yield of 7.20% pa
Public offer of the bonds has finished on 25.12.2020


Investing in bonds with a yield of 7.20% pa
Public offer of the bonds has finished on 25.12.2020.

The subscribed capital will be invested in the development of the companies.
Sale of bonds in the minimum amount of 150,000 CZK. The principal of the bond is due in 5 years, the coupon (interest) is paid quarterly. * Yield is subject to 15% withholding tax.

We invest in selected human assets.
FABA VENTURES supports companies with a positive impact on our environment, foodtech, biotech, education, AI, etc.

Obout us and
Our mission
FABA VENTURES is a subsidiary of the FABA LTD. Group, which entered the Czech market in February 2019 with the aim of investing in companies with a positive impact on our environment. The company invests through venture capital and private equity, where it acquires business shares in the companies it enters into.

Our mission is to become the largest venture capital company that supports revolutionary projects with a positive impact on our environment.

Company portolio
Seed / VC/ Private Equity
New concept of Gas Cooled Fast Reactor

NAPOLEON HR-4F represents a new concept of Gas Cooled Fast Reactor Generation IV. with the main aim hydrogen production.

Branislav has long years experience in the field of nuclear safety. He is an expert on design concepts, safety thermohydraulic analyses and thermomechanical behaviour of nuclear fuel. He has been responsible for and managed many diverse projects for Slovak nuclear power plants and participated in several EU research projects.

Biodegradable packaging material

whalecup is a new start-up focused on the development of biodegradable and ecological food packaging materials.

The company's CEO, Miss Anastasia Malysheva, graduated from the University of Chemical Technology with a specialisation in Alternative Energy and Environmental Science. She has practical skills and experience in bio fuels, conventional fuels, organic technologies and environmental chemistry.

AGORA Pharmaceuticals
Drug development against Alzheimer's disease

AGORA Pharmaceuticals s.r.o. is a biotech company established in 2015, focused on the development of novel drugs against neurodegenerative diseases, in particular, Alzheimer's disease.

CEO: Robert Flocius
Robert Flocius has 26 years of experience in all aspects of equity investments and venture capital. Former shareholder and co-founder of UB Networks Benelux Inc. - an American data communications company, which was the first Cisco Systems partner worldwide later sold to Newbridge for estimated USD 260 million which was further absorbed by the telecommunication giant Alcatel. Robert held the position of Chief Acquisition Adviser and shareholder at Madge Networks, the fastest growing British company in 1998, which under his leadership acquired Lannet an Israeli telecommunications company which resulted in creation of a 1.2 billion dollar company. He also co-founded Castelum Partners and Boston Capital Service, which were involved in restructuring and later selling the 130-year-old English investment bank Seymour Pierce.

© All Right Reserved. FABA VENTURES s.r.o.
Povltavská 74/5
Praha 7 - Troja
171 00